New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
12:20 EDTHPQ, MCD, UNXL, IN, HON, ZGNX, DECKOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday as some encouraging data from China offset increased worries about Europe fueled by the surprise resignation announcement from Italy's prime minister. Stocks opened quietly amid the international news. No movement was reported on the fiscal cliff negotiations, though the President and House Speaker John Boehner did meet yesterday, and investors may continue to stay on the sidelines until more clarity on that front emerges... ECONOMIC EVENTS: In the U.S., no major economic data was reported. In Europe, Italy's benchmark bond yields spiked and its stock market fell sharply after Prime Minister Mario Monti's surprise announcement of his intention to resign, which will likely prompt early elections. In China, industrial output had its best growth rate since March, rising 10.1% in November from a year ago. However, exports slowed sharply last month, rising 2.9% year over year after growing at an 11.6% pace in October. Import growth was unchanged from a year earlier, growing 2.4%... COMPANY NEWS: On the Dow, McDonald's (MCD) reported its global same-store sales rose 2.4% in November, driven mainly by strong results in the U.S. Shares rose about 1.3%, but could not catch up to Dow pacesetter Hewlett-Packard (HPQ), which jumped over 3.5% following speculation that activist investor Carl Icahn is building a stake, though CNBC's David Faber disputed those rumors... MAJOR MOVERS: Among the notable gainers was Uni-Pixel (UNXL), up 37% after rising over 18% Friday. The company said Friday it reached a deal for its technology to be used by "a large PC manufacturer" and this morning Craig-Hallum raised its price target on shares to $22 from $13. Also higher were shares of Intermec (IN), up 23% after agreeing to be acquired by Honeywell (HON) for $10.00 per share in cash. Among the noteworthy losers was Zogenix (ZGNX), down over 46% after an FDA advisory panel voted against recommending approval for its Zohydro ER pain drug. Also lower were shares of Deckers Outdoor (DECK), down more than 5% following cautious comments from Piper Jaffray regarding evidence of higher markdowns of UGG boots... INDICES: Near noon, the Dow was up 33.99, or 0.26%, to 13,189.12; the Nasdaq was up 13.46, or 0.45%, to 2,991.50; and the S&P 500 was up 2.81, or 0.20%, to 1,420.88.
News For HPQ;MCD;UNXL;IN;HON;ZGNX;DECK From The Last 14 Days
Check below for free stories on HPQ;MCD;UNXL;IN;HON;ZGNX;DECK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 15, 2014
06:06 EDTHPQHP implied volatility of 21 at lower end of index mean range
July 14, 2014
11:21 EDTHPQHP added to short-term buy list at Deutsche Bank
09:41 EDTHONHoneywell completes sale of FM business to Federal-Mogul
Subscribe for More Information
08:36 EDTZGNXZogenix announces patent for DosePro Needle-free Delivery System
Subscribe for More Information
08:34 EDTHPQPC market stability could be short-lived, Reuters says
Subscribe for More Information
July 11, 2014
08:49 EDTHPQJune CIO survey indicates strong 2H, says Morgan Stanley
Subscribe for More Information
July 10, 2014
18:02 EDTHPQWells sees 'shrinking list' of strategic buyers for Rackspace
Wells Fargo sees a "shrinking list" of potential buyers for Rackspace (RAX), with only remaining HP (HPQ) and CenturyLink (CTL) remaining in its opinion. Wells believes Rackspace going private through a leveraged buyout is a possibility, but it thinks such an outcome is a lower probability given the required return assumptions and implied exit multiple. The firm believes the market has correctly assumed a high probability that Rackspace will not undergo a strategic event. However, Wells thinks the potential for a value creating event limits downside in the name. It keeps an Outperform rating on the stock.
09:13 EDTHPQHP Western Digital Seagate to benefit from PC rebound, says RBC Capital
Subscribe for More Information
07:46 EDTHPQHP awarded computing, servers contract by USAF
HP announced that the United States Air Force, or USAF, has issued a Quantum Enterprise Buy, or QEB, procurement for select HP business PCs and Workstations. Products that will be distributed as part of the procurement include a wide array of business desktop and notebook PCs, including the HP Compaq Pro 6305 SFF, HP Z230 Workstation, HP Z820 Workstation, HP ProBook 640 G1 and the HP ZBook Mobile Workstations. Products acquired through this QEB award will be distributed to USAF bases and facilities around the world.
06:26 EDTHPQTablet quarterly shipments fall for first time to 56M on year, DigiTimes says
Subscribe for More Information
06:18 EDTHPQIDC: PC shipments in mature regions stabilizes market in Q2, DigiTimes
Subscribe for More Information
July 9, 2014
18:50 EDTHPQOn The Fly: After Hours Movers
Subscribe for More Information
18:17 EDTHPQHP, Lenovo shares up fractionally following PC shipment data
Shares of HP (HPQ) and Lenovo (LNVGY) are up fractionally after second quarter PC shipment data was released by Gartner and IDC. WHAT'S NEW: After eight quarters of declining shipments, worldwide PC shipments experienced flat growth in the second quarter of 2014, according to preliminary results by Gartner (IT). Worldwide PC shipments totaled 75.8M units in the second quarter, a 0.1% increase from the second quarter of 2013. According to the International Data Corporation, or IDC, Worldwide Quarterly PC Tracker, Worldwide PC shipments totaled 74.4M units in the second quarter of, a year-on-year decline of -1.7%. The results reflect the smallest decline in global PC shipments since the second quarter of 2012 when declining shipments of mini notebooks combined with a surge in tablet sales to disrupt the PC market. WHAT'S NOTABLE: According to IDC, the U.S. market showed strong 6.9% year-on-year growth in the second quarter. Continuing upgrades of Windows XP systems boosted shipments in commercial portables and desktops, helping the commercial segment. At the same time, retail acceptance of emerging product categories such as Chromebooks and ultraslims helped the consumer segment to stabilize. HP continued to hold the lead and gained 2% market share while four of the top 5 vendors experienced double-digit growth for the quarter. Lenovo and Toshiba (TOSBF) took advantage of some consumer interest in Windows 8 and a push to build up their presence in large enterprises. According to Gartner, Lenovo extended its lead as the leader in worldwide PC shipments, as its worldwide market share increased to 19.2%. Lenovo’s PC shipments grew by double-digits in all regions except Asia/Pacific. Lenovo’s shipment growth in Asia/Pacific was still faster than the regional average. OTHERS TO WATCH: Apple (AAPL), down marginally.
18:10 EDTHPQHP sources deny bid made for Rackspace, Re/code reports
Subscribe for More Information
09:04 EDTHONHoneywell's UOP green fuels technology selected by Petrixo
Subscribe for More Information
08:33 EDTZGNXZogenix reports positive development on U.S. District Court ruling
Zogenix commented on the order issued by the U.S. District Court in Massachusetts upholding its prior decision that imposing regulations to restrict access to Zohydro ER Extended-Release Capsules, CII, violates Constitutional law. The court's decision supports the importance of upholding the principle at the heart of this case, which is that the FDA is the only regulatory body that is authorized to determine the approval and access of medicines for all Americans. On October 25, 2013, the FDA approved Zohydro ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate, and today's decision preserves access for those in Massachusetts who may benefit from its medical attributes and sets a precedent for other states seeking to unjustly restrict access to Zohydro ER. Zogenix will continue to work to ensure patients have access to Zohydro ER in every state in a manner that is consistent with all extended-release opioids.
06:36 EDTHPQNotebook vendors shifting more orders to China makers, DigiTimes reports
Subscribe for More Information
July 8, 2014
14:15 EDTZGNXZogenix motion in suit with Massachusetts allowed in part, denied in part
A judge in the U.S. district court for Massachusetts allowed in part and denied in part Zogenix's motions in its battle with the state over regulations that Massachusetts is seeking to impose on the sales of its pain drug, Zohydro ER. The judge ruled that the company has stated a plausible claim for relief and the state's motion to dismiss was denied without prejudice. The company's motion to preliminarily enjoin the “LMN regulation” was allowed, but Zogenix has not met its burden of proof on the “pharmacist-only regulation” and its motion for a preliminary injunction on that regulation was denied without prejudice to renewal upon a more detailed submission, the judge wrote in the ruling. Note that shares of Zogenix remain down about 9% in afternoon trading, after its competitor, Purdue Pharma, announced earlier today that the FDA has granted Priority Review designation for its once-daily, single-entity hydrocodone bitartrate tablet, which competes with Zohydro ER. Reference Link
13:48 EDTZGNXZogenix drops 10% after competitor gets Priority Review
Shares of Zogenix (ZGNX) are moving lower after Purdue Pharma announced earlier today that the FDA has granted Priority Review designation for its once-daily, single-entity hydrocodone bitartrate tablet. The investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate for the purpose of misuse or abuse, Purdue stated. Shares of Zogenix, which has a competing pain killer drug called Zohydro ER without abuse-deterrent properties, are down 10%, or 22c, to $1.91 in afternoon trading.
06:34 EDTHPQHP shares attractively valued at current levels, says Deutsche Bank
Deutsche Bank says shares of HP are not adequately reflecting the company's innovation and increased R&D investment. Deutsche notes HP's new product introductions are up nearly two times versus three years ago. The firm views the stock as attractively valued and reiterates a Buy rating on HP with a $40 price target.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use